Table 3

Variable	rFSH, n=341			hp-hMG, n=115			Age<35 rFSH x hp-hMG	Age>35 rFSH x hp-hMG
Table 3. Subgroup analysis for younger and older patients.
Variable	Age<35 n=172	Age>35 n=162	p-value	Age<35 n=49	Age>35 n=66	p-value	Age<35 rFSH x hp-hMG	Age>35 rFSH x hp-hMG
Age(y)	33.80±1.19	37.24±1.29	<0.001	34.06±1.23	37.42±1.39	<0.001	0.186	0.330
BMI (Kg/m²)	23.13±3.87	23.57±3.95	0.417	23.93±5.96	23.79±4.30	0.898	0.357	0.758
Basal FSH (mUI/mL)	7.86±2.50	8.18±2.89	0.297	8.41±3.91	8.87 (3.72)	0.550	0.250	0.156
AFC (n)	14.65±6.44	12.87±5.56	0.02	13.80±7.02	10.29±4.69	0.003	0.467	0.001
Ovarian stimulation duration (days)	11.27±1.55	11.38±1.66	0.523	10.76±1.36	11.21±1.51	0.098	0.036	0.465
GT total dose^* (mIU/ML)	2968.58±850.88	3349.50±948.68	<0.001	3002.67±644.76	3457.11±870.50	0.003	0.526	0.316
Peak E2^* (pg/mL)	2734.08±1757.38	2373.08±1525.09	0.075	3453.24±2150.67	3478.43±2735.33	0.610	0.050	0.008
Peak P^* (ng/mL)	1.34±0.69	1.32±0.81	0.542	0.91±0.43	1.08±0.56	0.246	<0.001	0.011
Oocytes retrieved^* (n)	18.66±12.42	14.95±8.88	0.017	13.37±8.52	13.17±10.49	0.531	0.007	0.033
MII oocytes^* (n)	14.67±10.29	11.74±7.52	0.006	9.78±6.33	9.74±7.68	0.707	0.001	0.029
Maturaty rate(%)	77.96±14.32	78.00±18.74	0.985	75.31±20.45	74.95±74.95	0.928	0.304	0.287

Values are presented as mean (standard deviation) or number (%). A p value of <0.05 was considered significant.
^*The P value was calculated after log transformation for normal distribution.
rFSH, recombinant follicle-stimulating hormone; hp-hMG, highly purified-human menopausal gonadotropin; BMI, body mass index; FSH, follicle-stimulating hormone; AFC, antral follicle count; GT, gonadotropins; E2, estradiol; P, progesterone; MII, metaphase II
Note: Standard reference range: FSH: 1-9.2 mIU/mL